Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics
Molecules · 31.08.2023 · 28 (17) · 6375
DOI: 10.3390/molecules28176375 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 31.08.2023. Verfasst von Wolfgang Sadee. Beteiligte Einrichtung: Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA. Hauptthemen laut MEDLINE: Signal Transduction, Rhodopsin. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NCATS NIH HHS, NICHD.
Abstract (Originalsprache)
G-protein-coupled receptors (GPCRs) are ubiquitous sensors and regulators of cellular functions. Each GPCR exists in complex aggregates with multiple resting and active conformations. Designed to detect weak stimuli, GPCRs can also activate spontaneously, resulting in basal ligand-free signaling. Agonists trigger a cascade of events leading to an activated agonist-receptor G-protein complex with high agonist affinity. However, the ensuing signaling process can further remodel the receptor complex to reduce agonist affinity, causing rapid ligand dissociation. The acutely activated ligand-free receptor can continue signaling, as proposed for rhodopsin and μ opioid receptors, resulting in robust receptor activation at low agonist occupancy with enhanced agonist potency. Continued receptor stimulation can further modify the receptor complex, regulating sustained ligand-free signaling—proposed to play a role in opioid dependence. Basal, acutely agonist-triggered, and sustained elevated ligand-free signaling could each have distinct functions, reflecting multi-state conformations of GPCRs. This review addresses basal and stimulus-activated ligand-free signaling, its regulation, genetic factors, and pharmacological implications, focusing on opioid and serotonin receptors, and the growth hormone secretagogue receptor (GHSR). The hypothesis is proposed that ligand-free signaling of 5-HT2A receptors mediate therapeutic effects of psychedelic drugs. Research avenues are suggested to close the gaps in our knowledge of ligand-free GPCR signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Biology and Genetics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
- Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94158, USA.
- Aether Therapeutics Inc., Austin, TX 78756, USA.
ORCID-Profile: Wolfgang Sadee
Förderung
- NIDA NIH HHS
- NCATS NIH HHS
- NICHD
- NIDA
- Aether CRADA NCATS agreement
Zitieren
APA
Sadee, W. (2023). Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics. Molecules, 28(17), 6375. https://doi.org/10.3390/molecules28176375
Vancouver
Sadee W. Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics. Molecules. 2023;28(17):6375. doi:10.3390/molecules28176375
BibTeX
@article{Sadee2023,
author = {Sadee, Wolfgang},
title = {Ligand-Free Signaling of G-Protein-Coupled Receptors: Physiology, Pharmacology, and Genetics},
journal = {Molecules},
year = {2023},
volume = {28},
number = {17},
pages = {6375},
doi = {10.3390/molecules28176375}
}
EUVIMED